NCT04113226
- Conditions
- Chemotherapy, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-Cell Lymphoma (DLBCL), Nos, +18 more
- Locations
-
- CHU Amiens Amiens, France
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT02232516
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +32 more
- Locations
-
- City of Hope Duarte, California, United States
- Yale University New Haven, Connecticut, United States
- Northwestern University Chicago, Illinois, United States
- Weill Cornell Medicine New York, United States
NCT05978739
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
NCT03505554
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Irccs San Gerardo Dei Tintori Monza, Italy/MB, Italy
- UOC Ematologia, Ospedale S. Eugenio Roma, Italy
NCT04833114
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- UK Graz Universitätsklinik für Innere Medizin Klinische Abteilung für Hämatologie Graz, Austria
- LKH Hochsteiermark Standort Leoben Abteilung für Innere Medizin Department für Hämato-Onkologie Leoben, Austria
- Ordensklinikum Linz GmbH- Elisabethinen: I. Interne Abteilung Hämato-Onkologie Linz, Austria
- Kepler Universitätsklinikum Med Campus III, Univ.-Klinik für Hämatologie und Internistische Onkologie Linz, Austria
NCT02242097
- Conditions
- Contiguous Stage II Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Northwestern University- Lake Forest Hospital Lake Forest, Illinois, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Cleveland Clinic Cleveland, Ohio, United States
NCT02997761
- Conditions
- Adult B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +16 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT03494179
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Anhui Province Cancer Hospital Hefei, Anhui, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
NCT06224309
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
Completed
A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis
NCT05020652
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Guangdong Provincial Peoples Hospital Guangzhou, Guangdong, China
- West China School of Medicine / West China Hospital, Sichuan University Chengdu, Sichuan, China
- Institute of Hematology & Blood Diseases Hostpital, Chinese Academy of medical sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China